College of Agronomy and Biotechnology, National and Local Joint Engineering Research Center on Germplasm Innovation & Utilization of Chinese Medicinal Materials in Southwest China, Key Laboratory of Medicinal Plant Biology of Yunnan Province, Yunnan Agricultural University, Kunming, 650201, Yunnan, China.
Yunnan Characteristic Plant Extraction Laboratory, Kunming, 650106, Yunnan, China.
Planta. 2023 May 13;257(6):119. doi: 10.1007/s00425-023-04143-x.
Two UDP-glycosyltransferases from Panax vienamensis var. fuscidiscus involved in ocotillol-type ginsenoside MR2 (majonside-R2) biosynthesis were identified. PvfUGT1 and PvfUGT2 sequentially catalyzes 20S,24S-Protopanxatriol Oxide II and 20S,24R-Protopanxatriol Oxide I to pseudoginsenoside RT4/RT5 and RT4/RT5 to 20S, 24S-MR2/20S, 24S-MR2. Ocotilol type saponin MR2 (majonside-R2) is the main active component of Panax vietnamensis var. fuscidiscus (commonly known as 'jinping ginseng') and is well known for its diverse pharmacological activities. The use of MR2 in the pharmaceutical industry currently depends on its extraction from Panax species. Metabolic engineering provides an opportunity to produce high-value MR2 by expressing it in heterologous hosts. However, the metabolic pathways of MR2 remain enigmatic, and the two-step glycosylation involved in MR2 biosynthesis has not been reported. In this study, we used quantitative real-time PCR to investigate the regulation of the entire ginsenoside pathway by MeJA (methyl jasmonate), which facilitated our pathway elucidation. We found six candidate glycosyltransferases by comparing transcriptome analysis and network co-expression analysis. In addition, we identified two UGTs (PvfUGT1 and PvfUGT2) through in vitro enzymatic reactions involved in the biosynthesis of MR2 which were not reported in previous studies. Our results show that PvfUGT1 can transfer UDP-glucose to the C6-OH of 20S, 24S-protopanaxatriol oxide II and 20S, 24R-protopanaxatriol oxide I to form pseudoginsenoside RT4 and pseudoginsenoside RT5, respectively. PvfUGT2 can transfer UDP-xylose to pseudoginsenoside RT4 and pseudoginsenoside RT5 to form 20S, 24S-MR2 and 20S, 24S-MR2. Our study paves the way for elucidating the biosynthesis of MR2 and producing MR2 by synthetic biological methods.
从 Panax vienamensis var. fuscidiscus 中鉴定出两种参与 ocotillol 型人参皂苷 MR2(马钱苷-R2)生物合成的 UDP-糖基转移酶。PvfUGT1 和 PvfUGT2 依次催化 20S,24S-Protopanxatriol Oxide II 和 20S,24R-Protopanxatriol Oxide I 生成伪人参皂苷 RT4/RT5 和 RT4/RT5 生成 20S,24S-MR2/20S,24S-MR2。ocotillol 型皂苷 MR2(马钱苷-R2)是 Panax vietnamensis var. fuscidiscus(俗称“金平人参”)的主要活性成分,以其多种药理活性而闻名。目前,医药行业中 MR2 的使用依赖于从人参属植物中提取。代谢工程通过在异源宿主中表达它提供了生产高价值 MR2 的机会。然而,MR2 的代谢途径仍然神秘莫测,而且 MR2 生物合成中涉及的两步糖基化尚未报道。在这项研究中,我们使用定量实时 PCR 研究了 MeJA(茉莉酸甲酯)对整个人参皂苷途径的调控,这有助于我们阐明途径。我们通过比较转录组分析和网络共表达分析,发现了六个候选糖基转移酶。此外,我们通过体外酶反应鉴定了两种 UGT(PvfUGT1 和 PvfUGT2),它们参与了以前研究中未报道的 MR2 生物合成。我们的结果表明,PvfUGT1 可以将 UDP-葡萄糖转移到 20S,24S-原人参三醇氧化物 II 和 20S,24R-原人参三醇氧化物 I 的 C6-OH 上,分别形成伪人参皂苷 RT4 和伪人参皂苷 RT5。PvfUGT2 可以将 UDP-木糖转移到伪人参皂苷 RT4 和伪人参皂苷 RT5 上,形成 20S,24S-MR2 和 20S,24S-MR2。我们的研究为阐明 MR2 的生物合成和通过合成生物学方法生产 MR2 铺平了道路。